| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |